S. Marder

473 total citations
12 papers, 357 citations indexed

About

S. Marder is a scholar working on Psychiatry and Mental health, Social Psychology and General Health Professions. According to data from OpenAlex, S. Marder has authored 12 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 2 papers in Social Psychology and 2 papers in General Health Professions. Recurrent topics in S. Marder's work include Schizophrenia research and treatment (8 papers), Obsessive-Compulsive Spectrum Disorders (2 papers) and Mental Health and Psychiatry (2 papers). S. Marder is often cited by papers focused on Schizophrenia research and treatment (8 papers), Obsessive-Compulsive Spectrum Disorders (2 papers) and Mental Health and Psychiatry (2 papers). S. Marder collaborates with scholars based in United States, Germany and Austria. S. Marder's co-authors include David Braff, Christopher Reist, Manfred S. Green, Clifford Widmark, Stephen M. Erhart, Yuri Rassovsky, Mark J. Sergi, Jeffrey L. Boyd, Eric Granholm and Lawrence Friedhoff and has published in prestigious journals such as Schizophrenia Bulletin, Psychiatry Research and Schizophrenia Research.

In The Last Decade

S. Marder

12 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Marder United States	5	292	125	118	112	87	12	357
Stacey L. Eckert United States	6	346 1.2×	106 0.8×	91 0.8×	123 1.1×	138 1.6×	6	445
E. A. E. Holthausen Netherlands	9	379 1.3×	98 0.8×	90 0.8×	90 0.8×	131 1.5×	13	450
Giuseppe Piegari Italy	9	215 0.7×	99 0.8×	91 0.8×	85 0.8×	84 1.0×	18	301
F. Schultze-Lutter Switzerland	4	354 1.2×	144 1.2×	116 1.0×	201 1.8×	86 1.0×	4	421
James C. Seltzer United States	7	351 1.2×	78 0.6×	120 1.0×	123 1.1×	178 2.0×	8	416
Raj Haricharan Canada	6	514 1.8×	209 1.7×	88 0.7×	183 1.6×	101 1.2×	8	580
L. de Haan Netherlands	10	248 0.8×	99 0.8×	72 0.6×	112 1.0×	127 1.5×	20	403
Ori Elis United States	4	284 1.0×	120 1.0×	176 1.5×	100 0.9×	123 1.4×	4	395
T. Svirskis Finland	12	415 1.4×	156 1.2×	99 0.8×	145 1.3×	99 1.1×	17	496
Meram Can Saka Türkiye	9	254 0.9×	114 0.9×	68 0.6×	61 0.5×	60 0.7×	25	380

Countries citing papers authored by S. Marder

Since Specialization

Citations

This map shows the geographic impact of S. Marder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Marder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Marder more than expected).

Fields of papers citing papers by S. Marder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Marder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Marder. The network helps show where S. Marder may publish in the future.

Co-authorship network of co-authors of S. Marder

This figure shows the co-authorship network connecting the top 25 collaborators of S. Marder. A scholar is included among the top collaborators of S. Marder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Marder. S. Marder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Ikezawa, Satoru, et al.. (2024). The Phase III CONNEX programme assessing the efficacy and safety of iclepertin in patients with schizophrenia: Trial design and recruitment update. European Psychiatry. 67(S1). S87–S88. 1 indexed citations

Marder, S., I. Laszlovszky, Erzsébet Szalai, et al.. (2016). Efficacy of cariprazine on predominant negative symptoms of patients with schizophrenia: post hoc analysis of PANSS data, Marder factors, and cognition. European Neuropsychopharmacology. 26. S550–S550. 7 indexed citations

Keefe, Richard S.E., Sophia Vinogradov, Alice Medalia, et al.. (2010). FEASIBILITY STUDY OF MULTI-SITE COGNITIVE REMEDIATION IN THE SCHIZOPHRENIA TRIALS NETWORK (CRSTN). Schizophrenia Research. 117(2-3). 394–394. 3 indexed citations

Stover, Ellen, S. Marder, & William T. Carpenter. (2007). Progress on NIMH Initiatives (Memorial Theme for Wayne Fenton, MD). Schizophrenia Bulletin. 33(5). 1084–1085. 1 indexed citations

Sergi, Mark J., Yuri Rassovsky, Clifford Widmark, et al.. (2006). Social cognition in schizophrenia: Relationships with neurocognition and negative symptoms. Schizophrenia Research. 90(1-3). 316–324. 296 indexed citations

Rossotto, Elizabeth, Donna A. Wirshing, William C. Wirshing, et al.. (2003). Reducing rehospitalization rates for patients with schizophrenia: The community re-entry supplemental intervention. Schizophrenia Research. 60(1). 328–328. 5 indexed citations

Marder, S.. (1999). Antipsychotic drugs and relapse prevention. Schizophrenia Research. 35. S87–S92. 28 indexed citations

Umbricht, Daniel, Donna Ames, William C. Wirshing, et al.. (1997). Predictors of response to clozapine in a long-term double blind treatment study. Schizophrenia Research. 24(1-2). 189–189. 5 indexed citations

Gäebel, Wolfgang & S. Marder. (1996). Conclusions and treatment recommendations for the acute episode in schizophrenia. International Clinical Psychopharmacology. 11(Supplement 2). 93–100. 1 indexed citations

10.

Goldman, R.S., John A. Bates, Robert M. Bilder, et al.. (1996). The effects of clozapine and haldol on memory functioning in treatment refractory schizophrenics. Schizophrenia Research. 18(2-3). 221–221. 4 indexed citations

11.

Granholm, Eric, George Bartzokis, Robert F. Asarnow, & S. Marder. (1993). Preliminary associations between motor procedural learning, basal ganglia T relaxation times, and tardive dyskinesia in schizophrenia. Psychiatry Research. 50(1). 33–44. 3 indexed citations

12.

Glazer, William M., Lawrence Friedhoff, S. Marder, & Wendy J. Brown. (1992). The determination of the steady-state pharmacokinetic profile of fluphenazine decanoate by gas chromatography/mass spectrometry detection. Schizophrenia Research. 8(2). 111–117. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact